Männistö P
Int J Clin Pharmacol Biopharm. 1978 May;16(5):223-8.
The effect of four crystal sizes, gastric contents, and gastrointestinal motility on the absorption and excretion of nitrofurantoin was studied in three separate cross-over studies on 10 healthy volunteers. Microcrystal preparation gave an early and high serum peak. The greater the crystal size was, the smaller was the peak serum concentration. Correspondingly, microcrystal preparations gave initially very high nitrofurantoin concentrations in urine. Macrocrystal preparation had a not significantly longer excretion time than the other preparations. Food did not increase the serum nitrofurantoin concentrations, but excretion during 4 to 6 h was considerably greater than after fasting. In contrast, antacid and the use of a delayed-release preparation greatly worsened the biovailability of nitrofurantoin. An increased gastric emptying rate induced by metoclopramide significantly worsened the absorption of nitrofurantoin, but atropine only retarded the absorption and the principal excretion in urine occurred during 4 to 8 h.
在三项针对10名健康志愿者的独立交叉研究中,研究了四种晶体大小、胃内容物和胃肠蠕动对呋喃妥因吸收和排泄的影响。微晶制剂可产生早期且较高的血清峰浓度。晶体尺寸越大,血清峰浓度越低。相应地,微晶制剂最初在尿液中产生非常高的呋喃妥因浓度。大晶体制剂的排泄时间并不比其他制剂显著更长。食物不会增加血清呋喃妥因浓度,但4至6小时内的排泄量比空腹后显著增加。相比之下,抗酸剂和使用缓释制剂会大大降低呋喃妥因的生物利用度。甲氧氯普胺引起的胃排空率增加显著降低了呋喃妥因的吸收,但阿托品仅延迟了吸收,且尿液中的主要排泄发生在4至8小时内。